We'd like to introduce you to the new Brainomix identity, which reflects our company's world-class expertise and focus on delivering cutting-edge AI solutions for better treatment decisions.
The Oxford-based company at the forefront of medical AI imaging welcomes new Board members with pharmaceutical and imaging expertise
An update on some of the exciting developments from the first half of 2020
Brainomix committed to working with clinicians to make life-saving treatments accessible to all stroke patients
Event focused on NHS Long Term Plan and the role of AI solutions
Brainomix invites you to join us at ESOC 2019 to experience first-hand the most comprehensive imaging solution
Brainomix will be exhibiting at the 14th Congress of the World Federation of Interventional and Therapeutic Neuroradiology